Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - Ubiquitin-specific proteases - CB2 Receptors - PARP
清除全部
-
A8893 Rucaparib (free base)中文名: 瑞卡帕布Target: PARPSummary: PARP抑制剂 -
B2198 Nateglinide中文名: 那格列奈Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素促分泌剂 -
B2195 Gliclazide中文名: 格列齐特Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂 -
B2193 Mitiglinide Calcium中文名: 米格列奈钙Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂 -
B1425 BML-190中文名: 吲哚美辛吗啉代酰胺Target: CB2 ReceptorsSummary: CB2受体的配体 -
B1296 Glibenclamide中文名: 格列本脲Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素生产调节剂 -
B1429 Rimonabant3 Citation中文名: 利莫那班Target: CB1 Receptors|CB2 ReceptorsSummary: CB1 受体拮抗剂 -
A8808 ME0328Target: PARPSummary: PARP抑制剂 -
A8534 Terfenadine中文名: 特非那定Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) ChannelsSummary: 组胺H1受体拮抗剂 -
A3958 Veliparib dihydrochloride中文名: 维利帕尼二盐酸盐Target: PARPSummary: PARP-1/PARP-2抑制剂